# EDGAR Filing Document

**Accession Number:** 0001272842
**File Stem:** 0001193125-26-209133
**Filing Date:** 2026-5
**Character Count:** 98908
**Document Hash:** 09d5d2b6730f2921d8d0948f0ccac4ae
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-209133.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001193125-26-209133

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 82

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AIRGAIN INC
- **CENTRAL INDEX KEY:** 0001272842
- **STANDARD INDUSTRIAL CLASSIFICATION:** RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 954523882
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37851
- **FILM NUMBER:** 26949035

**BUSINESS ADDRESS:**
- **STREET 1:** 3611 VALLEY CENTRE DRIVE
- **STREET 2:** SUITE 150
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
- **BUSINESS PHONE:** (760) 579-0200

**MAIL ADDRESS:**
- **STREET 1:** 3611 VALLEY CENTRE DRIVE
- **STREET 2:** SUITE 150
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130

?xml version='1.0' encoding='ASCII'? 10-Q

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

------

**FORM** 10-Q

------

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE QUARTERLY PERIOD ENDED** **March 31,** 2026

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE TRANSITION PERIOD FROM TO** 

**Commission file number:** 001-37851

------

AIRGAIN, INC.

**(Exact name of registrant as specified in its charter)**

------

---

| | |
|:---|:---|
| Delaware | 95-4523882 |
| **(State or Other Jurisdiction of Incorporation or Organization)** | **(I.R.S. Employer Identification No.)** |
| 3611 Valley Centre Drive**,** Suite 150<br>San Diego**,** CA | 92130 |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**(**760**)** 579-0200

**(Registrant's Telephone Number, Including Area Code)**

------

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, par value $0.0001 per share | AIRG | Nasdaq Capital Market |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of April 29, 2026, the registrant had 12,675,780 shares of common stock (par value $0.0001) outstanding.

------

**AIRGAIN, INC.**

**Form 10-Q**

**For the Quarter Ended March 31, 2026**

---

| | |
|:---|:---|
|  | Page |
| &nbsp;&nbsp;&nbsp;&nbsp;**PART I. FINANCIAL INFORMATION** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 1. Condensed Consolidated Financial Statements (Unaudited)</u>](#part_i) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Balance Sheets</u>](#condensed_balance_sheets) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Operations</u>](#condensed_statements_operations) | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Comprehensive Loss</u>](#condensed_stmts_comprehensive_income) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Stockholders' Equity</u>](#statement_of_stockholdersequity) | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Cash Flows</u>](#statement_of_cashflows) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Notes to Condensed Consolidated Financial Statements</u>](#notes_to_condensed_financial_statements) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item_2_managements_discussion_analysis_f) | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 3. Quantitative and Qualitative Disclosures about Market Risk</u>](#item_3_quantitative_qualitative_disclosu) | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 4. Controls and Procedures</u>](#item_4_controls_procedures) | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;**PART II. OTHER INFORMATION** | &nbsp;&nbsp;&nbsp;&nbsp;**PART II. OTHER INFORMATION** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 1. Legal Proceedings</u>](#item_1_legal_proceedings) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 1A. Risk Factors</u>](#item_1a_risk_factors) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</u>](#item_2_unregistered_sales_equity_securit) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 3. Defaults Upon Senior Securities</u>](#item_3_defaults_upon_senior_securities) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 4. Mine Safety Disclosures</u>](#item_4_mine_safety_disclosures) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 5. Other Information</u>](#item_5_or_information) | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Item 6. Exhibits</u>](#item_6_exhibits) | 27 |
| [**<u>SIGNATURES</u>**](#signatures) | 28 |

---

------

**PART I. FINANCIAL INFORMATION**

**ITEM 1. FINANC** **IAL STATEMENTS**

**Airgain, Inc.**

**Condensed Consolidated Balance Sheets**

**(In thousands, except par value)**

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
|  | **(Unaudited)** |  |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $7127 | $7358 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable, net | 11272 | 12775 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 4066 | 3580 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 972 | 868 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 407 | 1177 |
| Total current assets | 23844 | 25758 |
| Property and equipment, net | 1591 | 1696 |
| Operating lease right-of-use assets | 3955 | 4166 |
| Goodwill | 10845 | 10845 |
| Intangible assets, net | 2999 | 2787 |
| Other assets | 157 | 85 |
| Total assets | $43391 | $45337 |
| **Liabilities and stockholders' equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $7071 | $9214 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | 870 | 1157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities and other | 2734 | 1790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term lease liabilities | 832 | 821 |
| Total current liabilities | 11507 | 12982 |
| Deferred tax liability | 190 | 186 |
| Long-term lease liabilities | 3679 | 3880 |
| Total liabilities | 15376 | 17048 |
| Commitments and contingencies (Note 13) |  |  |
| Stockholders' equity: |  |  |
| Common stock and additional paid-in capital, par value $0.0001, 200,000 shares authorized; 13,200 shares issued and 12,659 shares outstanding at March 31, 2026; and 12,666 shares issued and 12,125 shares outstanding at December 31, 2025. | 128911 | 127292 |
| Treasury stock, at cost: 541 shares at March 31, 2026 and December 31, 2025. | (5364) | (5364) |
| Accumulated deficit | (95532) | (93635) |
| Accumulated other comprehensive income |  | (4) |
| Total stockholders' equity | 28015 | 28289 |
| Total liabilities and stockholders' equity | $43391 | $45337 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**Airgain, Inc.**

**Condensed Consolidated Statements of Operations**

**(In thousands, except per share data)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Sales | $11511 | $12013 |
| Cost of goods sold | 6538 | 6853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 4973 | 5160 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 2249 | 2498 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 2330 | 2464 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 2507 | 3294 |
| Total operating expenses | 7086 | 8256 |
| Loss from operations | (2113) | (3096) |
| Other income (expense): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on business acquisition | 340 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee retention credit refund |  | 1494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income, net | 18 | 221 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (70) | (141) |
| Total other income (expense), net | 288 | 1574 |
| Loss before income taxes | (1825) | (1522) |
| Income tax expense | 72 | 24 |
| Net loss | $(1897) | $(1546) |
| Net loss per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.15) | $(0.13) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.15) | $(0.13) |
| Weighted average shares used in calculating loss per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 12306 | 11579 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 12306 | 11579 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**Airgain, Inc.**

**Condensed Consolidated Statements of Comprehensive Loss**

**(In thousands)** 

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Net loss | $(1897) | $(1546) |
| Other comprehensive loss: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | 4 | 1 |
| Comprehensive loss | $(1893) | $(1545) |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**Airgain, Inc.**

**Condensed Consolidated Statements of Stockholders' Equity**

**(In thousands)**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Fiscal Quarter Ended March 31, 2026** | **Fiscal Quarter Ended March 31, 2026** | **Fiscal Quarter Ended March 31, 2026** | **Fiscal Quarter Ended March 31, 2026** | **Fiscal Quarter Ended March 31, 2026** | **Fiscal Quarter Ended March 31, 2026** | **Fiscal Quarter Ended March 31, 2026** |
|  | **Common Stock And Additional Paid-In Capital** | **Common Stock And Additional Paid-In Capital** | **Treasury Stock** | **Treasury Stock** |  |  |  |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Accumulated Other Comprehensive (Loss) Income** | **Accumulated<br>Deficit** | **Total<br>Stockholders' Equity** |
| **Balance at December 31, 2025** | 12666 | $127292 | (541) | $(5364) | $(4) | $(93635) | $28289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  | (1897) | (1897) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  | 897 |  |  |  |  | 897 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued through restricted stock awards | 323 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued under ESPP | 20 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued through stock options | 20 | 94 |  |  |  |  | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments |  |  |  |  | 4 |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued in connection with at-the-market offerings, net | 171 | 628 |  |  |  |  | 628 |
| **Balance at March 31, 2026** | 13200 | $128911 | (541) | $(5364) | $- | $(95532) | $28015 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Fiscal Quarter Ended March 31, 2025** | **Fiscal Quarter Ended March 31, 2025** | **Fiscal Quarter Ended March 31, 2025** | **Fiscal Quarter Ended March 31, 2025** | **Fiscal Quarter Ended March 31, 2025** | **Fiscal Quarter Ended March 31, 2025** | **Fiscal Quarter Ended March 31, 2025** |
|  | **Common Stock And Additional Paid-In Capital** | **Common Stock And Additional Paid-In Capital** | **Treasury Stock** | **Treasury Stock** |  |  |  |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Accumulated Other Comprehensive (Loss) Income** | **Accumulated<br>Deficit** | **Total<br>Stockholders' Equity** |
| **Balance at December 31, 2024** | 12070 | $123546 | (541) | $(5364) | $(4) | $(87209) | $30969 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  | (1546) | (1546) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation |  | 945 |  |  |  |  | 945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued through restricted stock awards | 272 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock withheld related to net share settlement of equity awards | (44) | (190) |  |  |  |  | (190) |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued under ESPP | 25 | 123 |  |  |  |  | 123 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued through stock options | 12 | 24 |  |  |  |  | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments |  |  |  |  | 1 |  | 1 |
| **Balance at March 31, 2025** | 12335 | $124448 | (541) | $(5364) | $(3) | $(88755) | $30326 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**Airgain, Inc.**

**Condensed Consolidated Statements of Cash Flows**

**(In thousands)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **Cash flows from operating activities:** |  |  |
| Net loss | $(1897) | $(1546) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 99 | 123 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of property and equipment | 65 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 216 | 796 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on business acquisition | (340) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 707 | 907 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred tax liability | 4 | 5 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable | 1503 | 301 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (486) | 197 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 665 | 198 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (16) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (2146) | (1637) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | 21 | (183) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities and other | 825 | (364) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease liabilities | 21 | 178 |
| Net cash used in operating activities | (759) | (1025) |
| **Cash flows from investing activities:** |  |  |
| Purchases of property and equipment | (55) | (42) |
| Purchase of intellectual property | (88) |  |
| Net cash used in investing activities | (143) | (42) |
| **Cash flows from financing activities:** |  |  |
| Proceeds from at-the-market common stock offering, net of offering costs | 628 |  |
| Payments for withholding taxes related to net share settlement of equity awards |  | (191) |
| Proceeds from employee stock purchase and option exercises | 94 | 148 |
| Net cash provided by (used in) financing activities | 722 | (43) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 4 | 1 |
| Net decrease in cash, cash equivalents and restricted cash | (176) | (1109) |
| Cash, cash equivalents, and restricted cash; beginning of period | 7413 | 8565 |
| Cash, cash equivalents, and restricted cash; end of period | $7237 | $7456 |
| **Supplemental disclosure of non-cash investing and financing activities:** |  |  |
| Operating lease liabilities resulting from right-of-use assets | $— | $519 |
| Accrual of property and equipment | $4 | $8 |
| **Cash, cash equivalents, and restricted cash:** |  |  |
| Cash and cash equivalents | $7127 | $7401 |
| Restricted cash included in other assets | $110 | $55 |
| Total cash, cash equivalents, and restricted cash | $7237 | $7456 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**Airgain, Inc.**

**Notes to Condensed Consolidated Financial Statements**

**(Unaudited)**

**Note 1. Description of Business and Basis of Presentation**

***Description of Business***

Airgain, Inc. was incorporated in the State of California on March 20, 1995; and reincorporated in the State of Delaware on August 17, 2016. Airgain, Inc. together with its subsidiaries are herein referred to as the "Company," "we," or "our." Headquartered in San Diego, California, Airgain, Inc. (NASDAQ: AIRG) is a leading provider of advanced wireless connectivity solutions that drive cutting-edge innovation in 5G technology. We are committed to delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. Our mission is to connect the world through integrated, innovative, and optimized wireless solutions. Our diverse product portfolio serves three primary markets: enterprise, automotive, and consumer.

***Basis of Presentation and Principles of Consolidation***

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Interim financial results are not necessarily indicative of results anticipated for the full year. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, from which the balance sheet information herein was derived. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and investments have been eliminated in consolidation.

***Use of Estimates***

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

**Note 2. Summary of Significant Accounting Policies**

During the three months ended March 31, 2026, there have been no material changes to the Company's significant accounting policies as described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, except for the following:

***Business Combinations***

The Company applies the provisions of ASC 805, Business Combinations, in accounting for its acquisitions. It requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed, at the acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the acquisition date fair values of the net assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, as well as the contingent consideration, where applicable, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.

In addition, uncertain tax positions and tax-related valuation allowances assumed, if any, in connection with a business combination are initially estimated as of the acquisition date. The Company re-evaluates these items quarterly based upon facts and circumstances that existed as of the acquisition date with any adjustments to the preliminary estimates being recorded to goodwill if identified within the measurement period. Subsequent to the end of the measurement period or final determination of the estimated value of the tax allowance or contingency, whichever comes first, changes to these

------

uncertain tax positions and tax related valuation allowances will affect the income tax provision (benefit) in the consolidated statements of operations and could have a material impact on the results of operations and financial position.

***Recently Issued Accounting Pronouncements Not Yet Adopted***

In November 2024, the FASB issued ASU No. 2024-03, "Expense Disaggregation Disclosures (Subtopic 220-40)." The ASU requires public entities to disaggregate, in a tabular presentation, certain relevant income statement expenses into different categories, such as purchases of inventory, employee compensation, depreciation, and intangible asset amortization in commonly presented expense captions such as cost of sales, selling, general and administrative expense, and research and development. The guidance is effective for all public business entities in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted, and may be applied retrospectively. The Company intends to adopt the amendments in this update. The impact of the adoption of the amendments in this update is not expected to be material to the Company's consolidated financial position and results of operations, as the requirements only require more detailed disclosures in the footnotes to the Company's consolidated financial statements.

In January 2025, the FASB issued ASU 2025-01 to revise the effective date of ASU 2024-03 on disclosures of disaggregation of income statement expense. This guidance clarifies that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. The Company intends to adopt the amendments in this update. The impact of the adoption of the amendments in this update is not expected to be material to the Company's consolidated financial position and results of operations, as the requirements only require more detailed disclosures in the footnotes to the Company's consolidated financial statements.

In July 2025, the FASB issued ASU 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments provide a practical expedient that allows all entities to assume that conditions at the balance-sheet date will remain unchanged for an asset's remaining life when estimating credit losses on current accounts receivable and current contract assets arising from transactions under ASC 606. Entities electing this expedient will therefore adjust historical loss experience only to reflect current conditions, without the need to incorporate forward-looking forecasts. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods. The Company is currently evaluating the impact of adopting ASU 2025-05 and believes that the adoption will not have a material impact on the consolidated financial statements and related disclosures.

In September, 2025, the FASB issued ASU 2025-06, Targeted Improvements to the Accounting for Internal-Use Software. The amendments in this update require an entity to begin capitalizing internal-use software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. These amendments are effective for the Company for annual and interim periods in 2028, applied either prospectively, retrospectively, or by a modified approach, with early adoption permitted. As the Company does not currently have a material amount of software developed for internal use, the impact of the adoption of the amendments in this update is not expected to be material to the Company's consolidated financial position and results of operations.

In December 2025, the FASB issued ASU No. 2025-11, "Interim Reporting (Topic 270): Narrow-Scope Improvements", which updates and clarifies certain interim reporting requirements in Accounting Standards Codification (ASC) 270, including interim disclosure guidance and the reporting of material events and changes occurring after the most recent annual reporting period. The guidance is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of this guidance on our consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU No. 2025-12, "Codification Improvements", which amends various topics in the FASB ASC to correct technical errors, clarify guidance, and make other narrow-scope improvements to generally accepted accounting principles. The amendments in ASU 2025-12 address multiple areas of the Codification and are not expected to materially change current accounting practices. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact of this guidance on our consolidated financial statements and related disclosures.

**Note 3. Net Loss Per Share**

Basic net loss per share is calculated by dividing net loss available to common stockholders by the weighted average shares of common stock outstanding for the period. Diluted net loss per share is calculated by dividing net loss by the

------

weighted average shares of common stock outstanding for the period plus amounts representing the dilutive effect of securities that are convertible into common stock. The Company calculates diluted loss per common share using the treasury stock method.

The following table presents the computation of net loss per share (in thousands except per share data):

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **Numerator:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(1897) | $(1546) |
| **Denominator:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic weighted average common shares outstanding | 12306 | 11579 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted weighted average common shares outstanding | 12306 | 11579 |
| **Net loss per share:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.15) | $(0.13) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.15) | $(0.13) |

---

Potentially dilutive securities (in common stock equivalent shares) not included in the calculation of diluted net loss per share because to do so would be anti-dilutive are as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Stock options, restricted stock and performance stock | 2326 | 2065 |
| Common stock equivalent shares | 2326 | 2065 |

---

**Note 4. Cash and Cash Equivalents**

The following tables show the Company's cash and cash equivalents by significant investment category (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Cash | $7077 | $7237 |
| Level 1: |  |  |
| &nbsp;&nbsp;&nbsp;Money market funds | 50 | 121 |
| Total cash and cash equivalents | $7127 | $7358 |

---

At March 31, 2026, the fair value of the money market funds approximated its carrying amount.

***Restricted Cash***

As of March 31, 2026 and December 31, 2025, the Company had $110,000 and $55,000, respectively, in cash on deposit to secure certain lease commitments, which are restricted for more than twelve months and recorded in other assets in the Company's condensed consolidated balance sheet.

The Company's cash deposits exceeded the Federal Deposit Insurance Corporation's insured limits. The Company has not experienced losses on these accounts. Most of the Company's cash deposits are held in multiple accounts at a large institutional bank.

**Note 5. Inventories**

Inventories are comprised of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Finished goods | $3555 | $3134 |
| Raw materials | 511 | 446 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total inventories | $4066 | $3580 |

---

------

Consigned inventories, which are included in total inventories, are comprised of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Finished goods | $1306 | $1135 |
| Raw materials | 250 | 150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total consigned inventories | $1556 | $1285 |

---

**Note 6. Property and Equipment**

Depreciation and amortization of property and equipment is calculated on the straight-line method based on the shorter of the estimated useful life or the term of the lease for tenant improvements and three to ten years for all other property and equipment. Property and equipment consist of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Manufacturing and testing equipment | $4933 | $5630 |
| Leasehold improvements | 869 | 848 |
| Computers and software | 561 | 561 |
| Furniture, fixtures and equipment | 397 | 400 |
| Vehicles | 55 | 55 |
| Software development – internal use | 74 | 74 |
| Construction in process | 50 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, gross | 6939 | 7584 |
| Less accumulated depreciation | (5348) | (5888) |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | $1591 | $1696 |

---

Depreciation expense was $0.1 million for each of the three months ended March 31, 2026 and 2025. Accumulated depreciation for the quarter included $0.6 million that was related to disposal of manufacturing and testing equipment and furniture, fixtures and equipment.

**Note 7. Intangible Assets and Goodwill**

***Intangible Assets***

The following is a summary of the Company's acquired other intangible assets (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | **Weighted average amortization period (in years)** | **Gross carrying amount** | **Accumulated amortization** | **Net carrying amount** |
| Market related intangibles | 5 | $1850 | $(1821) | $29 |
| Customer relationships | 7 | 14040 | (13606) | 434 |
| Developed technologies | 11 | 4430 | (2418) | 2012 |
| Covenants to non-compete | 2 | 115 | (115) |  |
| Licensed technology | 3 | 892 | (368) | 524 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total intangible assets, net |  | $21327 | $(18328) | $2999 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Weighted average amortization period (in years)** | **Gross carrying amount** | **Accumulated amortization** | **Net carrying amount** |
| Market related intangibles | 5 | $1820 | $(1820) | $— |
| Customer relationships | 7 | 13780 | (13558) | 222 |
| Developed technologies | 11 | 4380 | (2327) | 2053 |
| Covenants to non-compete | 2 | 115 | (115) |  |
| Licensed technology | 3 | 804 | (292) | 512 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total intangible assets, net |  | $20899 | $(18112) | $2787 |

---

------

Amortization expense was $0.2 million and $0.8 million for the three months ended March 31, 2026 and 2025, respectively.

As of March 31, 2026, estimated future amortization expense related to intangible assets were as follows (in thousands):

---

| | |
|:---|:---|
|  | **Estimated future amortization** |
| 2026 (remaining nine months) | $705 |
| 2027 | 685 |
| 2028 | 343 |
| 2029 | 343 |
| 2030 | 343 |
| Thereafter | 580 |
| Total | $2999 |

---

***Goodwill***

There were no changes in the carrying amount of goodwill for the three months ended March 31, 2026 from December 31, 2025.

**No**t**e 8. Accrued Liabilities and Other**

Accrued liabilities and other are comprised of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Accrued expenses | $638 | $554 |
| Customer deposit | 1000 |  |
| Accrued income taxes | 72 | 3 |
| Contract liabilities | 122 | 129 |
| Goods received not invoiced | 533 | 775 |
| Other current liabilities | 369 | 329 |
| Accrued liabilities and other | $2734 | $1790 |

---

**Note 9. Business Acquisition**

On February 20, 2026, the Company acquired substantially all assets of the high-power user equipment (HPUE) product business from Nextivity. The acquisition expands the Company's product portfolio and is expected to provide synergies with its existing operations.

No cash, equity, or other consideration was transferred in connection with the acquisition, and the transaction represents a non-cash business combination.

***Assets Acquired***

The following table summarizes the fair value of identifiable intangible assets acquired as of the acquisition date (in thousands):

---

| | | |
|:---|:---|:---|
| **Category** | **Estimated life <br>(in years)** | **Fair value** |
| Finite-lived intangible assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer relationships | 5 | $260 |
| &nbsp;&nbsp;&nbsp;&nbsp;Developed technology | 5 | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market related intangibles | 5 | 30 |
| Total identifiable intangible assets acquired |  | $340 |

---

The Company did not assume any liabilities in connection with the acquisition.

The fair values of identifiable intangible assets were determined using commonly accepted valuation methodologies, including the multi-period excess earnings method for customer relationships and the relief-from-royalty method for

------

developed technology and trade names.

The following table represents the preliminary purchase price allocation recorded in the Company's unaudited condensed consolidated balance sheet as of the acquisition date (in thousands):

---

| | |
|:---|:---|
|  | **Amount** |
| Fair value of consideration transferred | $- |
| &nbsp;&nbsp;&nbsp;Less: Fair value of identifiable net assets acquired | (340) |
| Gain on bargain purchase | $340 |

---

As the fair value of the net assets acquired exceeds the fair value of the consideration transferred (zero consideration transferred), the Company recognized a gain on bargain purchase of $0.3 million, which was included in other income (expense) in the condensed consolidated statements of operations for the three months ended March 31, 2026. The Company reassessed the identification and measurement of all assets acquired and liabilities assumed prior to recognizing the gain.

The Company incurred $0.2 million of acquisition and integration-related costs, which were recorded in research and development, sales and marketing and general and administrative expenses on the condensed consolidated statements of operations.

From the acquisition date through March 31, 2026, the acquired business did not contribute material revenue or net loss to the Company's condensed consolidated results of operations.

The acquisition has been recorded using provisional amounts, as the purchase price allocation is incomplete. The Company expects to finalize the acquisition accounting during the measurement period, and any resulting adjustments will be recorded retrospectively.

**Note 10. Income Taxes**

The Company's effective income tax rate was -3.9% and -1.6% for the three months ended March 31, 2026 and 2025, respectively. The variance from the U.S. federal statutory rate of 21.0% for the three months ended March 31, 2026 was primarily attributable to the full valuation allowance position.

Management assesses its deferred tax assets quarterly to determine whether all or any portion of the asset is more likely than not unrealizable under Accounting Standards Codification (ASC) Topic 740. The Company is required to establish a valuation allowance for any portion of the asset that management concludes is more likely than not to be unrealizable. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company's assessment considers all evidence, both positive and negative, including the nature, frequency and severity of any current and cumulative losses, taxable income in carryback years, the scheduled reversal of deferred tax liabilities, tax planning strategies, and projected future taxable income in making this assessment.

As of December 31, 2025, the Company had a valuation allowance against net deferred tax assets of $18.5 million, however, the exclusion of a deferred tax liability generated by goodwill (an indefinite lived intangible) may not be considered a future source of taxable income in evaluating the need for a valuation allowance.

**Note 11. Stockholders' Equity**

***At-the-Market Offering***

In May 2025, the Company established an at-the-market offering program (2025 ATM Program) to sell up to $5.0 million of the Company's common stock. As of December 31, 2025, the Company had $4.6 million available under the 2025 ATM Program for future sales of its common stock.

During the three months ended March 31, 2026, the Company issued 171,488 shares of common stock under the 2025 ATM Program for net proceeds of $0.6 million after deducting commissions and other costs associated with the offering. As of March 31, 2026, the Company had $3.9 million available under the 2025 ATM Program for future sales of its common stock.

The Company recorded the 2025 ATM Program gross sales proceeds and offering costs in additional paid-in capital of the consolidated balance sheet. The following table summarizes the Company's 2025 ATM Program sales activity during the period indicated (in thousands):

------

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended March 31, 2026** | **December 31, 2025** |
| Shares issued | 171 | 109 |
| Gross proceeds | $705 | $439 |
| Net proceeds after offering costs | $628 | $167 |

---

**Note 12. Stock-Based Compensation**

***Stock-Based Compensation Expense***

Stock-based compensation expense is recorded in the consolidated statements of operations as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Cost of goods sold | $25 | $73 |
| Research and development | 146 | 270 |
| Sales and marketing | 132 | 73 |
| General and administrative | 404 | 491 |
| &nbsp;&nbsp;&nbsp;Total stock-based compensation expense | $707 | $907 |

---

***Stock Options***

The following table summarizes the outstanding stock option activity during the period indicated (shares in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | **Weighted average** | **Weighted average** |  |
|  | **Number of <br>stock options** | **Exercise <br>price** | **Remaining contractual term (in years)** | **Aggregate intrinsic value (in thousands)** |
| Balance at December 31, 2025 | 2418 | $9.07 | 5.5 | $169 |
| Granted | 350 | $4.19 |  |  |
| Exercised | (20) | $4.60 |  |  |
| Expired/Forfeited | (33) | $4.89 |  |  |
| Balance at March 31, 2026 | 2715 | $8.53 | 5.7 | $1193 |
| Vested and exercisable at March 31, 2026 | 2026 | $9.88 | 4.6 | $472 |
| Vested and expected to vest at March 31, 2026 | 2715 | $8.53 | 5.7 | $1193 |

---

The weighted average grant-date fair value of options granted during the three months ended March 31, 2026 was $2.32. The grant-date fair value of each option award is estimated on the date of grant, using the Black-Scholes-Merton option-pricing model.

As of March 31, 2026, there was $1.6 million of unrecognized stock-based compensation costs related to unvested stock options granted under the Company's equity plans. These costs are expected to be recognized over the next 2.4 years.

------

***Restricted Stock***

The following table summarizes the Company's restricted stock unit (RSU) activity during the period indicated (shares in thousands):

---

| | | |
|:---|:---|:---|
|  | **Restricted <br>stock units** | **Weighted average grant date fair value** |
| Balance at December 31, 2025 | 886 | $5.13 |
| Grants | 196 | $4.24 |
| Vested and released | (323) | $4.89 |
| Forfeited | (52) | $5.09 |
| Balance at March 31, 2026 | 707 | $5.50 |

---

As of March 31, 2026, there was $2.4 million of unrecognized stock-based compensation costs related to non-vested RSUs, which are expected to be recognized over a remaining weighted-average vesting period of 2.3 years.

***Share-Settled Obligations***

Share-settled compensation to non-employees was incurred and recognized as stock-based compensation expense and recorded in accrued expense. Within ninety days after the calendar year-end, the liabilities are settled in RSU grants and vest on the grant date. The share-settled obligations were $33.0 thousand and $0.1 million as of March 31, 2026 and December 31, 2025, respectively.

***Employee Stock Purchase Plan (ESPP)***

During the three months ended March 31, 2026, the Company received $0.1 million from the issuance of 19,785 shares under the ESPP.

**Note 13. Commitments and Contingencies**

***Potential Product Warranty Claims***

The Company had a general warranty accrual of less than $0.1 million as of March 31, 2026 and December 31, 2025.

***Indemnification*** 

In some agreements to which the Company is a party, the Company has agreed to indemnify the other party for certain matters, including, but not limited to product liability and intellectual property. To date, we have not recorded any material liabilities in the accompanying consolidated financial statements.

**Note 14. Concentrations**

***Concentration of Sales and Accounts Receivable***

The following represents customers that accounted for 10% or more of total revenue:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Customer A | 18% | 11% |
| Customer B | 15% | 37% |
| Customer C | 15% | 13% |
| Customer D | 10% | 3% |

---

------

The following represents customers that accounted for 10% or more of total trade accounts receivable:

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Customer A | 29% | 39% |
| Customer B | 17% | 20% |
| Customer C | 10% | 9% |

---

The allowance for credit losses was $0.2 million as of March 31, 2026 and December 31, 2025.

**Note 15. Revenue**

Disaggregated revenues are as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **By Market Group:** |  |  |
| Enterprise | $4952 | $4341 |
| Consumer | 5614 | 6401 |
| Automotive | 945 | 1271 |
| Total sales | $11511 | $12013 |
| **By Geography:** |  |  |
| North America | $5756 | $5221 |
| China (including Hong Kong and Taiwan) | 5641 | 6512 |
| Rest of the world | 114 | 280 |
| Total sales | $11511 | $12013 |
| **Timing of revenue recognition:** |  |  |
| Products and services transferred at a point in time | $10912 | $11188 |
| Products and services transferred over time | 599 | 825 |
| Total sales | $11511 | $12013 |

---

Contract liabilities are deferred revenues that were recorded when advance payments were received for remaining performance obligations that are recognized over time. The contract liabilities were $0.1 million each as of March 31, 2026 and December 31, 2025.

The Company has recorded sales return reserves based on analysis of historical return trends. As of March 31, 2026 and December 31, 2025, the Company had $0.2 million sales return reserves included in accrued liabilities and other on the consolidated balance sheets.

We have stock rotation return rights arrangements with certain customers to return a limited percentage of product. Estimated allowances for stock rotation were $0.1 million as of March 31, 2026, and December 31, 2025, and are included in the accrued liabilities in the accompanying condensed consolidated balance sheets.

**Note 16. Segment Information** 

Due to similarities of its products, methods of production and its management and administrative structure, the Company operates as a single operating and reportable segment.

The following table presents segment revenue, gross profit, net loss and certain operating financial results of the Company's single operating segment for the periods presented, as viewed by the CODM (in thousands):

------

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Sales | $11511 | $12013 |
| Less cost of goods sold: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other cost of goods sold | 6394 | 6642 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 25 | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 90 | 89 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 29 | 49 |
| Gross profit | 4973 | 5160 |
| Gross margin | 43% | 43% |
| Less research and development: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other research and development expenses | 2009 | 2116 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 146 | 270 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisition costs | 32 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance and exit costs |  | 47 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 62 | 65 |
| Total research and development | 2249 | 2498 |
| Less sales and marketing: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other sales and marketing expenses | 2075 | 2310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 132 | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisition costs | 120 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance and exit costs |  | 77 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 3 | 4 |
| Total sales and marketing | 2330 | 2464 |
| Less general and administrative: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other general and administrative expenses | 1950 | 2134 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 404 | 491 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 126 | 653 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisition costs | 22 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance and exit costs |  | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 5 | 5 |
| Total general and administrative | 2507 | 3294 |
| Loss from operations | (2113) | (3096) |
| Employee retention credit refund |  | 1494 |
| Employee retention credit - process costs |  | (134) |
| Interest income, net | 18 | 221 |
| Other income, net | 340 |  |
| Other segment (expenses) income <sup>(1)</sup> | (70) | (7) |
| Loss before income taxes | (1825) | (1522) |
| Income tax expense (benefit) | 72 | 24 |
| Net loss | $(1897) | $(1546) |

---

<sup>(1)</sup> Other segment expenses are primarily foreign currency transaction remeasurements and franchise taxes.

**Note 17. Subsequent Events**

On April 17, 2026, the Company terminated the employment of its Chief Technology Officer.

The Company is evaluating the impact of this change; however, no adjustments to the accompanying condensed consolidated financial statements were required.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*The following discussion and analysis and the interim unaudited condensed consolidated financial statements included in this quarterly report on Form 10-Q should be read in conjunction with the financial statements and notes thereto for the year ended December 31, 2025 and the related Management's Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in our Annual Report on Form 10-K for the year ended December 31, 2025. References to "Airgain, Inc.," "Airgain," the "Company," "we," "our" and "us" include Airgain, Inc. and our wholly owned subsidiaries.*

**Forward-Looking Statements**

This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). All statements other than statements of historical fact contained in this quarterly report, including statements regarding our future operating results, financial position and cash flows, our business strategy and plans, and our objectives for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "will," "would," "could," "should," "expect," "plan," "anticipate," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this quarterly report are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, operating results, business strategy, short-term and long-term business operations and objectives. These forward-looking statements speak only as of the date of this quarterly report and are subject to a number of risks, uncertainties and assumptions, including those described in Part II, Item 1A, "Risk Factors." The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

**Overview**

Airgain is a leading provider of advanced wireless connectivity solutions. We are focused on delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. Our mission is to connect the world through integrated, innovative, and optimized wireless solutions. Our diverse product portfolio serves three primary markets: enterprise, automotive, and consumer. While we have historically focused on high-performance radio frequency (RF) components, we are increasingly delivering integrated, system-level connectivity solutions that combine hardware, software and cloud management.

Our enterprise products include Smart Network Controlled Cellular Repeaters (Smart NCRs), embedded cellular modems, asset tracking solutions, and antennas for access points and Internet of Things (IoT) applications. Our automotive products include our second-generation AirgainConnect® Fleet system solution, and our aftermarket antennas. Our consumer products include embedded antennas for consumer access points, wireless gateways, and fixed wireless access (FWA) devices.

We have a rich history of providing RF expertise, services, and solutions to telecommunications operators and major original equipment manufacturers (OEMs). We leverage our RF and systems experience, and our Mobile Network Operator (MNO) and Multiple Service Operator (MSO) relationships, to deliver complex and differentiated system solutions.

***Markets***

The enterprise market demands reliable wireless access across diverse settings, including smart cities, campuses, stadiums, transportation hubs, utilities, buildings, and suburban developments.

Our Lighthouse platform in the enterprise market is a carrier-grade, high-power 5G smart repeater designed to extend coverage and offload capacity for MNO and system integrators. Lighthouse supports rapid deployment and does not

------

require wired backhaul, offering a cost-effective alternative to small cells and distributed antenna systems (DAS) for coverage enhancement. Our NimbeLink embedded modems serve numerous enterprise IoT sectors that require cellular connectivity, including packaging, logistics, EV charging, smart buildings, agriculture, and self-service innovations. These NimbeLink cellular modems, which are both patented and end-device certified, minimize the need for additional OEM end-customer carrier certifications. Our asset tracking solutions are deployed across transportation, supply chain, and other specialized applications. Our enterprise IoT and machine-to-machine (M2M) antennas are extensively deployed in diverse systems, products, and applications, including access points, gateways, FWA devices and utility meters.

In the automotive market, our products are deployed in a wide range of vehicles in the fleet and aftermarket applications, supporting a variety of technologies that include 5G, LTE, Wi-Fi, LPWAN, Global Navigation Satellite System (GNSS), and Bluetooth. Fleet and aftermarket products in the automotive market typically consist of applications where vehicular wireless routers are paired with external antenna systems to provide connectivity to mobile assets. In the third quarter of 2024, we completed the first commercial deployment of our second generation AirgainConnect® Fleet (AC-Fleet) system solution – a low profile, roof-mounted, all-in-one 5G vehicle gateway that provides 4G/5G cellular connectivity with built-in multi-profile eSIM, GNSS, Wi-Fi, and gigabit Ethernet router functionalities. We also offer a full line of external fleet antennas that are designed to be rugged, reliable, and flexible to meet almost any need. We design our products for performance, quality, and long product life, and our antennas connect to almost any vehicular router or modem. These antennas include high-performance and low-profile versions that mount on the roof, trunk, windshield, or dashboard and are optimized for 5G, 4G, Wi-Fi, and GNSS. On February 20, 2026, we acquired substantially all of the assets of the high-power user equipment (HPUE) product business from Nextivity. HPUE revenues are included in the automotive market.

The consumer market represents a vast audience utilizing wireless-enabled devices. Our embedded antennas are deployed in various consumer applications including access points, wireless gateways, FWA devices, Wi-Fi routers and extenders, and smart home devices. These consumer products support a variety of technologies, products and services, including 4G/LTE, 5G, Wi-Fi, Bluetooth, LPWAN and GNSS.

***Macroeconomic Conditions***

Macroeconomic conditions have continued to create demand softness and supply chain constraints in certain markets. Our sales declined by 4.2% compared with same period last year, as we experienced a demand softness in our existing automotive and enterprise markets, combined with excess inventories in our channels and direct customers. While we are experiencing demand growth with our consumer customers and enterprise IoT, we anticipate that the inventory surplus some of our automotive customers have may extend into the second half of 2026. We remain focused on the execution and commercialization of our strategic product initiatives, specifically design wins and revenue ramps of our AirgainConnect and Lighthouse platforms, which lay the foundation for our pursuit of revenue and profitability growth.

***Business Acquisition***

As discussed above, on February 20, 2026, we acquired substantially all of the assets of the HPUE product business from Nextivity. The acquisition expands our product portfolio and is expected to provide synergies with our existing operations.

No cash, equity, or other consideration was transferred in connection with the acquisition, and the transaction represents a non-cash business combination under the acquisition method of accounting, resulting in a non-recurring gain on business acquisition recorded in other income of condensed consolidated statements of operations.

**Factors Affecting Our Operating Results**

We believe that our performance and future success depend upon several factors including macro-economic and geopolitical uncertainties, import/export controls, and tariffs and trade policies of the United States and other countries, the impact of inflation on consumer spending, and our ability to transition from a component provider to a wireless systems provider and to develop technology leadership and expand our markets.

Our performance and future success also depend on factors such as continued investments in our growth, our ability to expand into growing addressable markets, including enterprise, automotive, and consumer, our ability to develop, market and sell advanced systems solutions that meet our customers' requirements, the average selling prices of our products and solutions, and manufacturing costs. Our customers are price conscious, and our operating results are affected by pricing pressure which may force us to lower prices below our established list prices. Our ability to maintain or increase our sales depends on, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•new and existing end customers selecting our solutions for their wireless devices and networks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•investments in our growth to address customer needs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•timely development of our differentiated product offerings and technology solutions;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•our ability to target new end markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the proliferation of Wi-Fi connected home devices and data intensive applications;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the impact of global supply shortages on our business and that of our end customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•international expansion in light of continuing global tensions and conflicts; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the ability to successfully integrate any future acquisitions.

In addition, inflation generally affects us by increasing our raw material and employee-related costs and other expenses. Our financial condition and results of operations may also be impacted by other factors we may not be able to control, such as uncertain global economic conditions, public health crises, global trade disputes, tariffs and trade policies, as well as conflicts around the world. We do not believe that such factors had a material adverse impact on our results of operations during the three months ended March 31, 2026.

While each of these areas presents significant opportunities for us, they also pose significant risks and challenges we must successfully address. We discuss many of these risks, uncertainties and other factors in greater detail in the section entitled "Risk Factors" included in this quarterly report on Form 10-Q and in Item 1A of our Annual Report on Form 10-K.

Our operating results historically have not been subject to significant seasonal variations. Although it is difficult to make broad generalizations, our sales tend to be lower in the first quarter of each year compared to other quarters due to the Lunar New Year. Results for any quarter may not be indicative of the results that may be achieved for the full fiscal year and these patterns may change because of general customer demand or product cycles.

**Key Components of Our Results of Operations and Financial Condition**

***Sales***

We primarily generate revenue from the sales of our products. We recognize revenue to depict the transfer of control over promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled for those goods or services. We generally recognize product sales at the time of shipment to our customers, provided that all other revenue recognition criteria have been met. We also generate service revenue from agreements to provide design, engineering, and testing services as well as subscription revenue from the sale of data plans.

***Cost of Goods Sold***

The cost of goods sold reflects the cost of producing antenna, embedded modem and system solutions products that are shipped to our customers as well as costs incurred for service agreements. This primarily includes manufacturing costs of our products payable to our third-party CMs. The cost of goods sold that we generate from services and subscription revenues primarily includes personnel costs and the cost to maintain data lines.

***Operating Expenses***

Our operating expenses are classified into three categories: research and development, sales and marketing, general and administrative. The largest component of expense is personnel costs, which includes salaries, employee benefit costs, bonuses, and stock-based compensation. Operating expenses also include allocated overhead costs for depreciation of equipment, facilities and information technology. Allocated costs for facilities consist of amortization of leasehold improvements as well as rent and utility expenses and taxes. Operating expenses are generally recognized as incurred.

*Research and Development*. Research and development expenses primarily consist of personnel and project development costs. These expenses include work related to the design, development and testing of system solutions and components. These expenses include salaries, stock-based compensation, benefits, bonuses, project development and testing, prototype material, consulting, travel, and similar costs, and depreciation and allocated costs for certain facilities. We expect research and development expenses to increase in absolute dollars in future periods as we continue to invest in the development of advanced system solutions, although our research and development expense may fluctuate as a percentage of total sales.

*Sales and Marketing*. Sales and marketing expenses primarily consist of personnel and facility-related costs for our sales, marketing, and business development personnel, stock-based compensation and bonuses earned by our sales personnel, and commissions earned by our third-party sales representative firms. Sales and marketing expenses also include the costs of trade shows, advertising, marketing programs, promotional materials, demonstration equipment, travel, and allocated costs for certain facilities. We expect sales and marketing expenses to increase in absolute dollars in future

------

periods as we continue to market and sell our advanced system solutions globally, although our sales and marketing expense may fluctuate as a percentage of total sales.

*General and Administrative*. General and administrative expenses primarily consist of personnel and facility related costs for our executive, legal, human resource, finance, and administrative personnel, including stock-based compensation, as well as legal, accounting, other professional services fees, depreciation and intangible amortization, and other corporate expenses. We expect general and administrative expenses to fluctuate as we grow our operations.

***Other Income (Expense)***

*Gain on business acquisition.* Gain on business acquisition represents the excess of the fair value of net assets acquired over the consideration transferred in connection with our acquisition of the HPUE business from Nextivity in February 2026. No consideration was transferred in the transaction, resulting in a non-recurring gain recorded in other income.

*Employee retention credit refund.* On March 27, 2020, the CARES Act was signed into law providing an ERC, which is a refundable tax credit against certain employment taxes on qualified wages. We applied for ERC refunds in 2023, totaling $2.8 million. During the three months ended March 31, 2025, we received ERC refunds of $1.5 million and an additional $0.5 million thereafter, for an aggregate of $2.0 million during the twelve months ended December 31, 2025. During the three months ended March 31, 2026, we did not receive any additional ERC refunds.

*Interest Income, net*. Interest income generally consists of interest earned on cash and cash equivalents and ERC-related interest, offset by interest expense which consists of interest charges on credit card charges and certain vendor bills.

*Other Income and Expense.* Other income and expense includes gain or loss on disposal of property and equipment, realized foreign exchange gains or losses, state franchise tax, and penalties.

***Provision for Income Taxes***

Provision for income taxes consists of federal, state and foreign income taxes. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. It is difficult for us to project future taxable income as the timing and size of sales of our products are variable. We concluded that it is not more likely than not that we will utilize our deferred tax assets other than those that are offset by reversing temporary differences.

------

**Results of Operations**

The following tables set forth our operating results for the periods presented and as a percentage of our total sales for those periods. The period-to-period comparison of financial results is not necessarily indicative of financial results to be achieved in future periods.

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **Statements of Operations Data (in thousands):** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales | $11511 | $12013 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of goods sold | 6538 | 6853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 4973 | 5160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 2249 | 2498 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 2330 | 2464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 2507 | 3294 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 7086 | 8256 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (2113) | (3096) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on business acquisition | 340 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee retention credit refund |  | 1494 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income, net | 18 | 221 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (70) | (141) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss before income taxes | (1825) | (1522) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 72 | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(1897) | $(1546) |

---

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **Statements of Operations Data:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales | 100.0% | 100.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of goods sold | 56.8 | 57.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 43.2 | 43.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 19.5 | 20.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 20.2 | 20.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 21.8 | 27.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 61.5 | 68.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (18.3) | (25.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on business acquisition | 3.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee retention credit refund |  | 12.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income, net | 0.1 | 1.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (0.7) | (1.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss before income taxes | (15.9) | (12.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 0.6 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | (16.5)% | (12.9)% |

---

------

**Comparison of the Three Months Ended March 31, 2026 (dollars in thousands)**

***Sales***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** | **$ Change** | **% Change** |
| Sales | $11511 | $12013 | $(502) | (4.2)% |

---

Sales for the three months ended March 31, 2026 decreased $0.5 million or 4.2% compared to the same period in the prior year, primarily due to lower sales of $0.8 million from the consumer market and $0.4 million from the automotive market, partially offset by higher sales of $0.7 million from the enterprise market.

***Cost of Goods Sold***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** | **$ Change** | **% Change** |
| Cost of goods sold | $6538 | $6853 | $(315) | (4.6)% |

---

Cost of goods sold for the three months ended March 31, 2026 decreased $0.3 million or 4.6% compared to the same period in the prior year. The decline was primarily due to lower sales.

***Gross Profit***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** | **$ Change** | **% Change** |
| Gross profit | $4973 | $5160 | $(187) | (3.6)% |
| Gross profit (percentage of sales) | 43.2% | 43.0% |  | 0.2% |

---

Gross profit for the three months ended March 31, 2026 decreased $0.2 million or 3.6%, compared to the same period in the prior year, driven by lower sales. Gross profit as a percentage of sales for the three months ended March 31, 2026 increased by 20 basis points compared to the same period in the prior year. The increase was primarily driven by improved consumer product margins, partially offset by lower enterprise product margins.

***Operating Expenses***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** | **$ Change** | **% Change** |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | $2249 | $2498 | $(249) | (10.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 2330 | 2464 | (134) | (5.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 2507 | 3294 | (787) | (23.9)% |
| Total operating expenses | $7086 | $8256 | $(1170) | (14.2)% |

---

Operating expenses for the three months ended March 31, 2026 decreased $1.2 million or 14.2% compared to the same period in the prior year. The decrease was primarily due to lower amortization of intangible assets and lower personnel expenses.

***Other Income (Expense)***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** | **$ Change** | **% Change** |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on business acquisition | $340 | $— | $340 | 100.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee retention credit refund |  | 1494 | (1494) | (100.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income, net | 18 | 221 | (203) | (91.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (70) | (141) | 71 | (50.4)% |
| Total other income (expense), net | $288 | $1574 | $(1286) | (81.7)% |

---

------

Total other income, net for the three months ended March 31, 2026 was $0.3 million compared with $1.6 million for the three months ended March 31, 2025. The decrease was primarily due to the receipt of $1.5 million employee retention credit refunds in the first quarter of 2025 that was not repeated in the current period, partially offset by a bargain purchase gain of $0.3 million associated with the HPUE business acquisition.

***Income Tax Expense***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** | **$ Change** | **% Change** |
| Income tax expense | $72 | $24 | $48 | 200.0% |

---

Income tax expense for the three months ended March 31, 2026 increased $48 thousand or 200.0% compared to the same period in the prior year primarily due to higher income tax expense accruals in 2026 as compared to 2025.

**Liquidity and Capital Resources**

We had cash and cash equivalents of $7.1 million at March 31, 2026. During the period from 2013 through 2025, we incurred several years of net losses. As a result, we have an accumulated deficit of $95.5 million as of March 31, 2026.

We plan to continue to invest for long-term growth, including expanding our engineering and sales teams to execute on our product roadmap and further penetrate domestic and international markets. We anticipate that these investments will continue to increase in absolute dollars. We believe that our existing cash and cash equivalents balance will be sufficient to meet our working capital requirements for at least the next 12 months.

The following table presents a summary of our cash flow activity for the periods set forth below (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Net cash used in operating activities | $(759) | $(1025) |
| Net cash used in investing activities | (143) | (42) |
| Net cash provided by (used in) financing activities | 722 | (43) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 4 | 1 |
| Net decrease in cash, cash equivalents and restricted cash | $(176) | $(1109) |

---

***Net cash used in operating activities.*** Net cash used by operating activities was $0.8 million for the three months ended March 31, 2026. This was primarily driven by the net loss of $1.9 million, offset by $0.8 million non-cash expenses and $0.3 million net change in operating assets and liabilities.

***Net cash used in investing activities.*** Net cash used in investing activities of $0.1 million for the three months ended March 31, 2026 was primarily for purchases of property and equipment and intellectual property.

***Net cash provided by financing activities.*** Net cash provided by financing activities of $0.7 million for the three months ended March 31, 2026 was primarily from $0.6 million of net proceeds from issuance of 171,488 shares of common stock via our at-the-market offering program (2025 ATM Program), and $0.1 million proceeds from option exercises.

***At-the-Market Sales Agreement***

In May 2025, we established the 2025 ATM Program, to sell at our option up to $5.0 million of our common stock, pursuant to an amended and restated sales agreement (the Sales Agreement) with Craig-Hallum Capital Group LLC (Craig-Hallum) as sales agent or principal. As of December 31, 2025, we had $4.6 million available under the 2025 ATM Program for future sales of our common stock. During the three months ended March 31, 2026, we issued 171,488 shares of common stock under the 2025 ATM Program for net proceeds of $0.6 million after deducting commissions and other costs associated with the offering. As of March 31, 2026, we had $3.9 million available under the 2025 ATM Program for future sales of our common stock.

We are not obligated to sell, and Craig-Hallum is not obligated to buy or sell, any shares of common stock under the Sales Agreement. No assurance can be given that we will sell any additional shares of common stock under the 2025 ATM Program, or, if we do, as to the price or amount of shares of common stock that we may sell or the dates when such sales will take place.

------

***Liquidity and Capital Resources Assessment***

As of March 31, 2026, management performed the annual assessment of the Company's ability to meet its obligations as they become due within one year based on relevant conditions and events that are known and reasonably knowable. Following ASC 205-40 guidance, management considered quantitative and qualitative information to evaluate the Company's ability to meet obligations. Based on the analysis of the relevant conditions and events that are known and reasonably known as of March 31, 2026, the Company concluded that it is probable that it will be able to meet all of its financial obligations as they become due in the next twelve months.

The relevant conditions and events that are known and reasonably known as of May 6, 2026 related to the Company have not significantly changed since March 31, 2026. Therefore, the expected cash inflows along with the existing funds are expected to be sufficient for the Company's financial obligations as they become due in the next twelve months.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

**ITEM 4. CONTROLS AND PROCEDURES**

***Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures***

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic and current reports that we file with the Securities and Exchange Commission (SEC) is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this quarterly report on Form 10-Q. Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

***Changes in Internal Control Over Financial Reporting***

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

We are not currently subject to any material legal proceedings. From time to time, we may be involved in legal proceedings or subject to claims incident to the ordinary course of business. Regardless of the outcome, such proceedings or claims can have an adverse impact on us because of defense and settlement costs, diversion of resources, and other factors, and there can be no assurances that favorable outcomes will be obtained.

**ITEM 1A. RISK FACTORS**

A description of the risk factors associated with our business is included in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to such risk factors. In evaluating our business, you should carefully consider the risk factors discussed in our Annual Report on Form 10-K. The occurrence of any of such risks, or other events that we do not currently anticipate or that we currently deem immaterial, could harm our business, prospects, financial condition and results of operations. In that case, the trading price of our common stock could decline, and you may lose all or part of your investment.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

**Unregistered Sales of Equity Securities**

None.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

None.

**ITEM 5. OTHER INFORMATION**

**Director and Officer Trading Arrangements:** 

***Rule 10b5-1 Trading Plans*** 

From time to time, our officers (as defined in Rule 16a-1(f) of the Exchange Act) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K).

During the three months ended March 31, 2026, no director or officer adopted, modified or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.

------

**ITEM 6. EXHIBITS**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **EXHIBIT INDEX** | **EXHIBIT INDEX** | **EXHIBIT INDEX** | **EXHIBIT INDEX** | **EXHIBIT INDEX** | **EXHIBIT INDEX** |
|  |  | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** |  |
| **Exhibit**<br>**Number** | **Exhibit Description** | **Form** | **Date** | **Exhibit Number** | **Filed Herewith** |
| 3.1 | [<u>Amended and Restated Certificate of Incorporation</u>](https://www.sec.gov/Archives/edgar/data/1272842/000119312516684194/d416747dex31.htm) | 8-K | 08/17/2016 | 3.1 |  |
| 3.2 | [<u>Amended and Restated Bylaws, effective as of February 1, 2023</u>](https://www.sec.gov/Archives/edgar/data/1272842/000095017023001895/airg-ex3_1.htm) | 8-K | 02/06/2023  | 3.1 |  |
| 4.1 | [<u>Specimen stock certificate evidencing the shares of common stock</u>](https://www.sec.gov/Archives/edgar/data/1272842/000119312516663212/d168839dex41.htm) | S-1 | 07/29/2016 | 4.1 |  |
| 31.1 | [<u>Certification of Principal Executive Officer pursuant to Rules 13a-14 and 15d-14 promulgated pursuant to the Securities Exchange Act of 1934, as amended</u>](airg-ex31_1.htm) |  |  |  | X |
| 31.2 | [<u>Certification of Principal Financial Officer pursuant to Rules 13a-14 and 15d-14 promulgated pursuant to the Securities Exchange Act of 1934, as amended</u>](airg-ex31_2.htm) |  |  |  | X |
| 32.1\* | [<u>Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</u>](airg-ex32_1.htm) |  |  |  | X |
| 32.2\* | [<u>Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</u>](airg-ex32_2.htm) |  |  |  | X |
| 101.INS | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |  |  |  |  |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |  |  |  |  |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  |  |  |  |

---

\* These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | AIRGAIN, INC. |
| Date: May 6, 2026 | /s/ Jacob Suen |
|  | Jacob Suen<br>President and Chief Executive Officer<br>(principal executive officer) |
| Date: May 6, 2026 | /s/ Michael Elbaz |
|  | Michael Elbaz<br>Chief Financial Officer and Secretary<br>(principal financial and accounting officer) |

---

------

## Exhibit 31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jacob Suen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Airgain, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Jacob Suen |
|  | Jacob Suen |
|  | President and Chief Executive Officer |
|  | (principal executive officer) |

---

------

## Exhibit 31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael Elbaz, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Airgain, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Michael Elbaz |
|  | Michael Elbaz |
|  | Chief Financial Officer and Secretary |
|  | (principal financial officer) |

---

------

## Exhibit 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Airgain, Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Jacob Suen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Jacob Suen |
|  | Jacob Suen |
|  | President and Chief Executive Officer |
|  | (principal executive officer) |

---

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

------

## Exhibit 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Airgain, Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael Elbaz, Chief Financial Officer and Secretary of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: May 6, 2026 | /s/ Michael Elbaz |
|  | Michael Elbaz |
|  | Chief Financial Officer and Secretary |
|  | (principal financial officer) |

---

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

------